Organ Transplant Center and Hepatobiliary Sciences Department, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
PLoS One. 2022 Jun 2;17(6):e0268044. doi: 10.1371/journal.pone.0268044. eCollection 2022.
Renal transplantation is the definitive treatment for patients with end-stage renal disease (ESRD). It is associated with better quality of life and patient survival. Nevertheless, these benefits come with rising concerns about weight gain and metabolic abnormalities, which adversely impact transplant outcomes.
The objective of this study is to estimate the incidence of weight gain in the first year post-renal transplant in addition to the assessment of potential risk factors and the resulting outcome of the graft.
We conducted a single-center retrospective cohort study of all 295 patients who underwent kidney transplantation at King Abdulaziz Medical City (KAMC) between January 2016 and December 2019. Clinical and laboratory variables were collected from electronic records. Continuous variables were reported as mean ± standard deviation. Comparison between groups was assessed by unpaired t-test or Mann-Whitney U test while follow-up data were compared using paired t-test and repeated measures ANOVA. Association between the potential risk factors and the weight gain was assessed by means of binary logistic regression analysis.
Significant weight gain was observed in 161 (54.6%) patients. Females were 119 (40.30%) of the cohort. The mean age was 45.3±15.1 years. The prevalence of diabetes was 234 (79.6%), while hypertensives constituted 77 (26.3%). The comparison between patients who gained weight significantly and patients with stable weight showed a numerical higher prevalence of female gender in patients who had more weight gain (44.1% vs. 35.8%), higher diabetes, higher rate of a living donor, and statistically significant lower dialysis duration before transplant. Other clinical and laboratory variables were comparable between the two groups.
Our study showed a high incidence of clinically significant weight gain among patients post-renal transplantation. Patients with lower dialysis duration, a living kidney donor and those who are obese at baseline were at higher risk of gaining weight. Patients who underwent kidney transplantation should be monitored closely for weight gain and further studies are needed to determine the risk factors and appropriate interventions.
肾移植是终末期肾病(ESRD)患者的明确治疗方法。它与更好的生活质量和患者存活率有关。然而,这些好处伴随着对体重增加和代谢异常的担忧日益增加,这对移植结果产生了不利影响。
本研究旨在估计肾移植后第一年体重增加的发生率,以及评估潜在的危险因素和移植物的结果。
我们对 2016 年 1 月至 2019 年 12 月在阿卜杜勒阿齐兹国王医疗城(KAMC)接受肾移植的 295 例患者进行了单中心回顾性队列研究。从电子记录中收集临床和实验室变量。连续变量以平均值±标准差表示。通过未配对 t 检验或曼-惠特尼 U 检验评估组间比较,使用配对 t 检验和重复测量方差分析比较随访数据。通过二元逻辑回归分析评估潜在危险因素与体重增加之间的关联。
161 例(54.6%)患者出现明显体重增加。女性占队列的 119 例(40.30%)。平均年龄为 45.3±15.1 岁。糖尿病患病率为 234 例(79.6%),高血压患者为 77 例(26.3%)。与体重稳定的患者相比,体重明显增加的患者比较显示,体重增加较多的患者中女性比例更高(44.1%比 35.8%),糖尿病更高,活体供者比例更高,移植前透析时间更短,统计学上有显著差异。两组间其他临床和实验室变量无差异。
我们的研究表明,肾移植后患者体重明显增加的发生率较高。透析时间较短、活体供肾者和基线肥胖的患者体重增加的风险较高。接受肾移植的患者应密切监测体重增加,并需要进一步研究确定危险因素和适当的干预措施。